ArticleCommunications medicine2025
Vaccination for prevention of hearing loss: a scoping review.
Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Factors and mitigating strategies impacting receipt of healthcare by the Deaf community: an umbrella review.BMC health services research · 2026Pooled it
- Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfectious diseases in childhood and adolescence are significant and often preventable causes of hearing loss, especially in low- and middle-income countries. We conducted a scoping review to examine the extent, range and nature of available evidence on the role of vaccination for prevention of hearing loss worldwide.
methodsWe reviewed the published scientific literature to identify studies providing quantitative information on the relationship between vaccination and hearing loss. We searched four databases: MEDLINE, EMBASE, Cochrane Library and Global Index Medicus. No date, language, or geographical restrictions were imposed. Two independent reviewers assessed eligibility and charted data.
resultsHere we show that vaccination may be a key, underexploited strategy for primary prevention of child and adolescent hearing loss. Although the important contributions of rubella and meningitis vaccinations to hearing loss prevention are widely recognised, we identify 26 distinct known or potential infectious causes of hearing loss that are preventable or possibly preventable through vaccination. Notwithstanding, we find a dearth of empirical evidence on the impacts of vaccination on hearing loss prevention. In addition, the review identifies no research from low- and middle-income countries, which bear the overwhelming burden of child and adolescent hearing loss. Finally, it shows that numerous vaccines that address priority infectious diseases relevant to hearing loss are in development and could be brought into use.
conclusionsWe recommend strategic investment in research concerning vaccination as a strategy for primary prevention of child and adolescent hearing loss.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.